chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received 1st Covid-19 Pfiser Vaccine shot on Thursday February 11, 2021. Patient received the 2nd Covid-19 Pfiser Vaccine on  Thursday,  March 4, 2021.  7 days after second vaccine shot on Thursday, March 11, 2021, patient showed some symptoms of a itchy-horsed throat & a slight dry cough. Called doctors - they said nothing to worry about, drink hot fluids and take couch drops. It went away in 2-3 days. Exactly 4 weeks after second Covid-19 Pfiser vaccine on Thursday, April 1st 2021, patient was sent to the ER for a seizure.
Information has been received from a physician concerning a female who was a premature infant with a history of seizures as an infant (no current seizure history) who was vaccinated with a first dose of GARDASIL. Subsequently, the patient had a seizure the following day. The patient sought unspecified medical attention. At the time of the report the patient's outcome was recovered. Upon internal review, the seizure was considered to be an other important medical event. Additional information has been requested.
partial loss of vision , starting 7 p.m. vaccine admin 10:45 am , 2 hours loss on vision and ongoing distorted vision ,blurriness, heart palpitations
very exhausted; throat was very very itchy; Muscle ache; Joint pain; heart palpitations; This spontaneous case was reported by a nurse and describes the occurrence of THROAT IRRITATION (throat was very very itchy), MYALGIA (Muscle ache), ARTHRALGIA (Joint pain), PALPITATIONS (heart palpitations) and FATIGUE (very exhausted) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced THROAT IRRITATION (throat was very very itchy), MYALGIA (Muscle ache), ARTHRALGIA (Joint pain) and PALPITATIONS (heart palpitations). On 04-Feb-2021, the patient experienced FATIGUE (very exhausted). At the time of the report, THROAT IRRITATION (throat was very very itchy) had resolved and MYALGIA (Muscle ache), ARTHRALGIA (Joint pain), PALPITATIONS (heart palpitations) and FATIGUE (very exhausted) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: No specific follow-up information recorded.
rash where shot was given,rash is bigger than a 50 cent piece; started itching, so patient scratched it; rash where shot was given; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (rash where shot was given,rash is bigger than a 50 cent piece), VACCINATION SITE PRURITUS (started itching, so patient scratched it) and VACCINATION SITE RASH (rash where shot was given) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for Blood pressure.    On 20-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, the patient experienced VACCINATION SITE RASH (rash where shot was given). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (rash where shot was given,rash is bigger than a 50 cent piece) and VACCINATION SITE PRURITUS (started itching, so patient scratched it). At the time of the report, VACCINATION SITE ERYTHEMA (rash where shot was given,rash is bigger than a 50 cent piece), VACCINATION SITE PRURITUS (started itching, so patient scratched it) and VACCINATION SITE RASH (rash where shot was given) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested.
This spontaneous report as received from a other health professional refers to a male patient of unknown age. The patient was vaccinated with dose 1 GARDASIL on an unknown date (dose, route, site of administration and lot number not reported). No other co-suspects were reported. No concomitant medications were reported. It was stated that on an unknown date, after receiving his first dose the patient had a red rash on his chest and neck a couple of hours later. No treatment information was reported. The outcome of red rash on his chest and neck is unknown. The relatedness for red rash on his chest and neck is unknown for GARDASIL. Additional information is not expected.
Father received vaccine on May 13, 2021.  Complained of migraine headaches, feeling tired, and generally unwell. Migraines became more persistent.  Father died on June 16, 2021 at home.  Coughed up blood and vomited around time of death.
It was for aspiration pneumonia. They gave me many medications in the hospital, but they gave me Levaquin and Flagyl after being discharged. I went in because in the 3 previous months when I had pneumonia, I knew I needed to go in because I was sick. I was in the hospital 04/06 through  04/09. I was discharged. I'm supposed cut out on tea and beer. I'm also supposed to cut on fats and eliminate chocolates. No more caffeinated drinks. No beer. The other cases of pneumonia were more severe. Twice by ambulance. After those two, I noticed what the problems were and that's why I went to the hospital. It was noted that with GERD, the acid was coming up into my lungs and that's what had caused the aspiration pneumonia. I've had 4 cases of pneumonia in the last 120 days.
irregular/menstrual cycle has been unbalanced, It has been on and off/ when it did come, it was not a normal cycle; my menstrual cycle was about to start and it was three weeks delayed/ cycle was started on the 10Sep2021; it was like a heavy cycle with heavy blood clots; normally my cycles are heavy but they were light; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0217), via an unspecified route of administration, administered in Arm Right on 24Aug2021 at the age of 45-year-old as dose 1, single for covid-19 immunisation. Medical history included high blood pressure from an unknown date and unknown if ongoing. Concomitant medications included amlodipine and losartan. The patient experiencing irregular and menstrual cycle has been unbalanced. It has been on and off. Patient got the vaccine on 24Aug2021, the same day when menstrual cycle was about to start and it was three weeks delayed. The cycle was started on the 10Sep2021 and it was not a normal cycle. Normally her cycles are heavy, but they were light. On 27Sep2021 it was like a heavy cycle with heavy blood clots. So, it is like starting like the first day of her menstrual. On same day patient talked to the doctor who advised should monitor it for 7 days and if still is happening then patient need to consult again or if she is using more than like a pad or the tampons fill with up the blood within an hour, then patient advised to go to the urgent care of the hospital. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Approx couple  weeks after vaccination hands started to swell, followed by cough, fatigue, low grade fever, shortness of breath.  Blood test indicates now positive for auto immune disorder. Still being evaluated
This spontaneous report was received from a certified medical assistant, refers to unspecified patients of unknown ages and genders. Concomitant condition and medical history were not reported. On unspecified dates, the patients were vaccinated with doses of GARDASIL injection, lot # K006960, expiration date on 19-FEB-2017 (strength, dose #, dose, anatomical and route of administration were not reported), which were exposed to temperatures outside of the recommended range. There was not concomitant medication reported. Product quality complaint was not involved. No adverse experience has been reported. Additional information has been requested.
Had gotten the Shingles vaccine on 11/26/2022; Started feeling sick on 11/28/2022 with uncontrollable bladder and diarrhea especially when I'd cough; I started vomiting on 12/01/2022 and doctor advised me to go to the ER; Went to the hospital and was tested for Influenza and COVID-19; Tested negative for the Flu, but tested positive for COVID-19; Was admitted to the hospital and put in a room by myself and given an IV of Edemlivere for 5 days and TYLENOL as needed for fevers; Was in the hospital from 12/1/2022 through 12/09/2022; Also gave me MUCINEX and cough syrup and tablets; After I was discharged they kept me taking MUCINEX; After I got home I was still had a cough with some of the diarrhea with no appetite; Because of my Kidney disease they continuously test my blood and urine about every 2 to 3 days; Found out that I had a UTI, was given an antibiotic, took for 5 days and it cleared it up.
Stressed at work experienced discomfort jaw, no other s/s. Person paramedic did owe EKG showed left atrial enlargement. Resolved did not see MD. No previous cardiac condition advised to MD refused. (copy attached).
20 minutes after vaccine - dysequilibrium and sensation of vision being blurry. Developed cough and wheezing.
Moderna COVID-19 Vaccine EUA.  Nine days after shot my arm felt sore at injection site only with redness surrounding injection area. Also warm to touch, hard and swollen. I put CBD cream on area to help with inflammation and soreness.
Patient received 2 Pfizer COVID-19 vaccines 3 days apart.   Minor presented with a consent form signed by her mother on 8/8/21.  Vaccine was administered.  After administration, the patient stated that she thought she had received the vaccine 3 days prior.  Mother had forgotten that she had signed the form and took patient to receive from the pharmacy.   No signs of adverse events from having received the extra dose.
Pt reported swelling, redness, and warmth to the back of her left upper arm where she received the injection. Pt also c/o fatigue.
Had the shot, got shingles/Suspected vaccination failure; Shingles, mild case; Awful pain; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 01-MAR-2023 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient had the shingles shot and still got shingles.  The patient stated that, it was awful pain and it was a mild case. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
i can feel the site where they gave me the shot, not terribly sore; I'm tired.; This is a spontaneous report from a Pfizer-sponsored program from a non-contactable female consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Feb2021 11:40 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history included back pain from an unknown date and unknown if ongoing. Concomitant medication was not reported. The patient previously took Tylenol for back pain, at approximately 9pm, the night before vaccine dose. The patient asked if the Tylenol is going to affect vaccine. The patient reported that she received 1st dose yesterday (20Feb2021) at approximately 11:40am. "Today, morning after dose, caller says, i can feel the site where they gave me the shot, not terribly sore, but I'm tired.  I'm worried that I don't have a lot of side effect, is it working? " The outcome of the events was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Severe leg pain. Skin hypersensitivity. Dizziness. Chills
A LITTLE BIT OF REACTION; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced a little bit of reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of a little bit of reaction was not reported. This report was non-serious.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021 at 11:36 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Mar-2021 at 11:36 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 73.62  Concomitant products were not provided.  On 20-Mar-2021 Excursion time was reported at 09 am and 10 am with temperature as 34 and 37 degrees Fahrenheit respectively, total doses given for the day was 184, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 09-Mar-2021, vial was moved to clinic on 20-Mar-2021. 19 vials were sent to clinic. Vaccine BUD date was 08-Apr-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
Pt vaccinated with TD developed moderate swelling, redness & tenderness rt upper arm. Warm, moist packs to affected area advised. Tylenol.
10/10/21 , pregnant with second child and currently 200 lbs  I had a reaction of severe itching and hives
Had Hep A and Hep B shots on 4/4/09. Felt sick and nauseated at the time. Returned on 4/5/09 c/o inability to remove R arm and nausea and vomiting.
Seizure and subsequent apnea/bradypnea at home at 4:00 pm, bradycardia at 4:10-4-15 PM during transport by EMS to hosptial. Intubated, placed on ventilator and stabilized at primary hospital. Lab findings showed hyperglycemia, ketonuria, Diabetic ketoacidosis, anemia, leukocytosis, thrombocytopenia, dehydration, subdural hematoma. Transported to specialty hospital, weaned off of ventilator. Then suffered additional seizures and respiratory arrest- reintubated.   Hospital stay 7 days, currently on anti-seizure medication.
Since receiving the vaccine, I have experienced two separate incidents of severe break through menstrual bleeding. This is extremely rare for me as my periods are typically very regular and predictable.
Initial report received from a health care professional on 03/May/2006. A 19-year-old male patient with a medical history of seasonal allergies had received an injection on Menomune A./C/Y/W-135, lot number UE483AA, administered intra-muscularly in the right deltoid on 01/May/2006. One day later, the patient developed nausea and vomited once. He had cold sweats, joint and muscle aches. He also experienced a single cramp in his left leg. The patient did not have a fever. As per the reporter, the patient was to be evaluated by a physician on 03/May/2006. At the time of this report the patient's recovery status was unknown. Follow-up information received on 22/May/2006. Per the reporter, the patient had received allergy shots on the date of vaccination, and his age was 18-year-old. He was not examined by a physician for the event. Per the reporter, the patient had received the immunization late in the afternoon, and the symptoms began in the "middle of the night". On 04/May/2006, the parent indicated that he had fully recovered.
Minor achy; flu like symptoms; This is a spontaneous report received from a non-contactable consumer. A male patient of unspecified age received a dose of BNT162B2 (TRADE NAME UNSPECIFIED; lot number unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced minor achy and flu like symptoms. The clinical outcomes of minor achy and flu like symptoms were unknown.  No follow-up attempts are possible; information about lot number cannot be obtained.
Spasm all over my back; back pain; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Spasm all over my back), BACK PAIN (back pain), CHILLS (Chills) and PYREXIA (Fever) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included MELOXICAM for Arthritis, MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced CHILLS (Chills) and PYREXIA (Fever). On 28-Apr-2021, the patient experienced MUSCLE SPASMS (Spasm all over my back) and BACK PAIN (back pain). The patient was treated with PARACETAMOL (TYLENOL) for Back pain, at a dose of 3 dosage form every four hours. At the time of the report, MUSCLE SPASMS (Spasm all over my back) and BACK PAIN (back pain) had not resolved and CHILLS (Chills) and PYREXIA (Fever) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.
Headache, Myalgia, Fever, Diarrhea & NauseaVomiting Narrative: Per nursing report: "2nd dose of COVID 19 vaccine administered on 2/2/21. New symptoms of body aches, fever (101.0), nausea, diarrhea, headache"
A non-serious spontaneous report of administration of expired product has been received from a Registered Nurse concerning a female employee "in her 20's" who received FLUMIST. Medical history and concomitant medications were not reported. On 15-Dec-2008, the patient was administered FLUMIST which expired on 12-Nov-2008. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from the previous season and 2) product expiring during the peak of the flu season resulting in some medication errors that occurred shortly after the product expired. Additional information received on 29-Dec-2008 and incorporated into the narrative included patient demographics and lot number of FLUMIST. The reporter confirmed there were no late-occurring adverse events. Follow-up information was received on 09-Apr-2009: Product Complaint Investigation results.
Constant pain in left arm. The upper part, and constant pain in my left arm where shot was given. Also it hurts to lift my arm.
Rec'd MENVEO vaccine on 8/05/13. Seen for reaction in office 8/7/13. S/S equal LT deltoid, upper arm with edema, 12cm x 10cm warm, red area. No induration; non-tender; denies pain, afebrile Tx; ibuprofen, ice packs. Pt. to call back  if pain, fever occur.
Hives in right hand, shoulder, and face; This is a spontaneous report from a non contactable consumer (patient).  A 51-years-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 04Aug2021 (Batch/Lot Number: Fa7484) age at vaccination of 51-years-old, as single dose, for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included zinc (ZINC) taken for an unspecified indication, start and stop date were not reported; fexofenadine hydrochloride (ALLEGRA) taken for an unspecified indication, start and stop date were not reported; aspirin [acetylsalicylic acid] (ASPIRIN) taken for an unspecified indication, start and stop date were not reported; alprazolam (XANAX) taken for an unspecified indication, start and stop date were not reported; escitalopram oxalate (LEXAPRO) taken for an unspecified indication, start and stop date were not reported; hydrochlorothiazide, triamterene (DIU) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient experienced hives in right hand, shoulder and face on 04Aug2021; event was considered as non serious (no hospitalization required). Therapeutic measures were taken as a result of the event and included administration of daily Benadryl. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was not recovered    No follow-up attempts are needed. No further information is expected.